ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
다우존스 지수
44,296.51
0.97%
Bitcoin
97,958.44
-1.09%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avita Medical Inc (RCEL)

  7. Avita Medical Inc (RCEL) 뉴스

Avita Medical Inc

Avita Medical Inc (RCEL)

NASDAQ
13.34
0.47
(3.65%)
마감 24 11월 6:00AM
15분 지연
13.29
-0.05
(-0.37%)
시간외 거래: 8:19AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

RCEL 뉴스

공식 뉴스 전용

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
09 8월 2024
RCEL (3.65%)

Form 8-K - Current report
Edgar (US Regulatory)
01 8월 2024
RCEL (3.65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 6월 2024
RCEL (3.65%)

RCEL Discussion

게시물 보기
pick pick 2 월 전
This happened in my backyard. I live near Powhatan and read of the fire. (There are a lot of horse farms around here; Powhatan and Chesterfield counties, where I live are suburds of Richmond, where VCU is located. VCU Hospital was formerly known as the Medical College of Virginia)

It's good PR for Avita, and the widespread used of Recell. 
👍️0
Fmello Fmello 3 월 전
Medical director uses new technology to save horse’s skin after massive barn fire

https://www.12onyourside.com/2024/08/02/medical-director-uses-new-technology-save-horses-skin-after-massive-barn-fire/
👍️0
Spetch Spetch 4 월 전
Hi guys, what the hell just happened? We come out with a new product and it drops 10%.
👍️0
Spetch Spetch 4 월 전
Come on bod
Let’s see you put some money where your mouth is As this long-term drop is ridiculous
👍️0
Dretired Dretired 5 월 전
These individual news story need to be developed in all the metropolitan areas throughout the country.
👍️0
Dretired Dretired 5 월 전
Yes good reference post.
👍️0
Spetch Spetch 5 월 전
Hi guys
Would be nice to see some of the board put some money into this would show confidence in the new product
What are your thoughts?
👍️0
Monksdream Monksdream 5 월 전
RCEL under $10
👍️0
Cake10 Cake10 6 월 전
RECELL Go Gets FDA Approval

Massive!!

THIS IS THE WAY.

https://ir.avitamedical.com/news-releases/news-release-details/avita-medical-announces-fda-approval-recell-go
👍️0
believeinsteven believeinsteven 6 월 전
Morningstar: Avita Medical Shares Remain Undervalued, With Long-Term Opportunity Intact
👍️ 1
Trueheart Trueheart 7 월 전
Gratifying? It's my best guess that you're the type that drives by horrible traffic accidents, slowing down to view the carnage, the blood and mangled bodies, just so's you can have something to say that will distract your wife from her crossword puzzle as you're eating dinner.
Be a mensch!

Trueheart
👍️0
Spetch Spetch 7 월 전
Hi all
Would be nice to see the directors making some share buys at these low prices to show confidence in the future
👍️0
Fmello Fmello 7 월 전
https://www.ktnv.com/news/unique-burn-treatment-helps-logandale-girl-recover-nearly-scar-free-at-las-vegas-hospital
👍️0
Monksdream Monksdream 8 월 전
RCEL over $10
👍️0
Cake10 Cake10 9 월 전
As I stated, how he opines is immaterial (despite the fact that he’s on record for liking the company, which is why he had Perry on twice and talked about liking the product many times thereafter). But that was a long time ago. Though positive sentiment never hurts, his “OPINEion” is largely immaterial in the scheme of the facts: FDA approvals, broadening scope, increasing sales, plenty of cash, halo product, and a path to profitability, to mention a few.

And, yes, he does do quite intensive research. He may be wacky, but he’s extremely thorough and highly intelligent. Both he and CNBC have extensive resources and staff that do serious due diligence. I assure you he will see what we ALL see. And he will like A LOT. Maybe all of it. But yes, in the final analysis, he may hedge because of the market cap. Or because they’re not yet profitable though that’s not an intransigent sentiment with him. He mainly holds that position in a risk-off environment with recessionary risk or looming rate hikes as we’ve been in the last couple years.

But these days are different. Have you seen Bitcoin lately? Upcoming IPOs? Anticipated rate cuts? We’re in a very different market than a few months ago and he may change his tune, especially when this company will be profitable by next year. Or he may not. Doesn’t really matter.

No — this is ALL about visibility. Institutions are very well aware of this stock with a couple having taken deep bites, but the retail investor by and a large? I don’t know. This stock is/was mostly held by retail last I checked, but that doesn’t necessarily indicate plurality. Many may have it off their radars these days. Many may just need a couple of positive comments that piques their interest and jives with their risk tolerance. This is who I would expect to come looking. Thousands will look. Some will buy. Maybe small fish. Maybe big fish. There’s no way to know. All I’m saying is “hold on tight.” TiGETTY-tight.

PS: relying “on the new executives executing what seems like a very workable strategy” is in no way shape or form mutually exclusive to gaining massive visibility. Both can be had.
👍️0
MONYMAN3 MONYMAN3 9 월 전
I'm afraid he may not opine positively. You know he doesn't recommend stocks that aren't making money? Also, as you say, market cap may not be big enough. If he really did intensive research, I believe he would come out with a positive recommendation. If anything, that would give us a short term pop. Better to rely on the new executives executing what seems like a very workable strategy.
👍️0
Cake10 Cake10 9 월 전
Mad Money episode tonight 2/29/24 … on Leap Day of all days.

Caller: Cramer what do you think about Avita Medical?

Cramer: I do not know this company! I will have to do some work.

First of all, the question surprised me. Second, I was surprised they allowed the call to go through as the show, I believe, requires a company to have a minimum market cap of $1B or $1.5B for it to be discussed. He had Mike Perry ON his show twice (once in person) around 2019 or 2020 during its huge run up toward all-time highs when it was around that market cap. He will definitely remember once his staff does their due diligence. This is a FAR more advanced company than it was then.

Usually (maybe always) he’ll do a follow-up with his “homework” updating viewers on questions about stocks on which he was stumped by callers.

This should be VERY interesting, not necessarily because of what he does/doesn’t have to say (you should rely on your own research), but for the mere fact that he has a massive audience and massive platform for visibility.

Hold on VERY tightly to your shares until if/that segment airs, potentially within the next few weeks.
👍️ 1
artfulife artfulife 9 월 전
Feb 29 (Reuters) - AVITA Medical Inc(RCEL):

* AVITA MEDICAL SUBMITS RESPONSE TO FDA, RESUMING REVIEW CLOCK FOR RECELL GO PMA SUPPLEMENT

* AVITA MEDICAL INC(RCEL) - EXPECT FDA APPROVAL ON MAY 30, 2024, POSITIONING US FOR A PRODUCT LAUNCH ON MAY 31, 2024

Yes!
👍️0
MONYMAN3 MONYMAN3 9 월 전
https://ir.enovix.com/events/event-details/journey-scale-podcast-feb-2024-fab2-updates-coo-ajay-marathe
👍️0
MONYMAN3 MONYMAN3 10 월 전
https://seekingalpha.com/news/4056668-cantor-picks-rcel-as-best-2024-medtech-idea-bullish-on-pacb-axgn-cers
👍️0
Fmello Fmello 10 월 전
👍️ 2
Fmello Fmello 10 월 전
The Aussie stock closed up 12.59% tonight.
👍️0
Fmello Fmello 10 월 전
https://www-presseportal-de.translate.goog/pm/167421/5687690?_x_tr_sl=de&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

PMI CEO Christian Planck: "We are very pleased that we can now offer RECELL ® in Germany, Austria and Switzerland. Our customers have been asking about this technology for years. In fact, it is a perfect addition to our own portfolio the one- stop shop technology."

"Our partnership with PolyMedics Innovations is the first step in our strategic global expansion," said Jim Corbett, Chief Executive Officer of AVITA Medical. "PMI's proven track record and expertise in the global distribution of innovative wound treatments make them an ideal partner. We look forward to a successful collaboration that will enable us to reach more patients worldwide."
👍️0
MONYMAN3 MONYMAN3 12 월 전
https://us02web.zoom.us/rec/play/D_NT2rl2dZcpc7L_XUt6VJh81E_HIM21mngBXR6KjZHRPs0VCBfzNWiyCOb7vHVaubUpQSvF7WhSZaPB.oSXXXZT66WOzvHuC?hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2FDh9UFDWQhFjYF0S9afouXwsCKphzVngmXyS6lDfdDuXYk52XXdCrVctLIq0WiYkA.PO58b8CAaqc_JBTL RCEL Investor Webinar
👍️0
Fmello Fmello 1 년 전
Here's a detailed presentation about Recell.
(warning: some of the pics are very graphic)

https://avitamedical.showpad.com/share/NAPlEVouN92Enz79yKX4z
👍️0
believeinsteven believeinsteven 1 년 전
“We have achieved significant commercial revenue growth rates for
the last three quarters of 40%, 42% and 51%, respectively, over the
same periods in the previous year,” said David O’Toole, Chief
Financial Officer of AVITA Medical. “Further, we remain confident
that our cash reserves position us to achieve our goals and reach
profitability in 2025.”
👍️0
Spetch Spetch 1 년 전
Hi
Not the worst results ever moving forward
👍️0
artfulife artfulife 1 년 전
He's just making the rounds with another "told you so" post. 🎱🦨 😄
👍️0
Windbag1014 Windbag1014 1 년 전
You're back.
Pull all the wings off the flies? Lots of legless grasshoppers in your neighborhood. No dead people to pick on? Oh the gratification.
👍️0
bar1080 bar1080 1 년 전
Gratifying watching much "Perpetual Startup" crap collapsing. Thinking of Plug Power, LWLG (Lightwave Logic), SolarWindow, Liquidmetal.... and maybe several hundred more. This market rewards large caps with audited profits and regular cash dividends. Bad news for IHUB and its dead stock boards and company insiders drawing monstrously large wages for running itty bitty penny stocks where success is always "just around the corner."

Also: "Wow, I see this board is >ten years old. I don't buy tiny biomed stocks. Most are perpetual startups. Vapor. I require GAAP profits and usually dividends.
But I make money with my investments." https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171926857
👍️0
Spetch Spetch 1 년 전
Why the total free fall of share price
Any comments
Thanks steve
👍️0
Align Align 1 년 전
Apologies, it looks like I was wrong about preliminary results.
👍️0
Align Align 1 년 전
After listening to what the CEO had to say about sales momentum during two conferences in September, preliminary results and revenue guidance upgrades are possible this week in my view.

The next scheduled event after that is the earnings call and investor briefing in November where they’ll be providing earnings results, strategies on future expansions and hopefully additional commentary on the revised expectations on Recell Go approval.
👍️0
Spetch Spetch 1 년 전
Hi
Any idea next event that could turn share price around
Fall was to much for what is short delay in terms of things
👍️0
Fmello Fmello 1 년 전
That drop seems pretty excessive.
👍️0
Spetch Spetch 1 년 전
So over reaction by market
👍️0
Windbag1014 Windbag1014 1 년 전
As previously disclosed, on June 30, 2023, AVITA Medical, Inc. (the
“Company”) submitted a premarket approval supplement application
(the “PMA”) to the U.S. Food and Drug Administration (the “FDA”)
for its latest device, RECELL GO™. The submission initiated a
prioritized, interactive review of the PMA under the FDA’s
Breakthrough Device program, which follows a 180-day review
cycle.


At the halfway point of the process, the Company received notice
from the FDA that additional information regarding the PMA is
required for the continuation of a substantive review. This
request, which is not unique to the Breakthrough Device Program,
places the application file on hold for approximately 4 to 6 months
while the Company addresses the FDA's questions. Upon the Company’s
submission of a complete response to the FDA’s request, the
application will reenter the 180-day cycle, with 90 days remaining
in the review period. This timing would imply a product launch
between May 1 and July 1, 2024.
👍️0
Spetch Spetch 1 년 전
I’m in the UK, so don’t quite understand what this form relates to
👍️0
Spetch Spetch 1 년 전
Hi chaps, can anyone explain why 20% down thank you
👍️0
Windbag1014 Windbag1014 1 년 전
https://ih.advfn.com/stock-market/NASDAQ/avita-medical-RCEL/stock-news/92172037/form-8-k-current-report
👍️0
believeinsteven believeinsteven 1 년 전
What did I miss? Why the drop in share price?
👍️0
MONYMAN3 MONYMAN3 1 년 전
https://us02web.zoom.us/rec/play/8LuDNA4gvw9rySzh-Jq5hf2dN49r88m2nCZKTtexSjouqZawLCRgGbt1nh2P-tNaDJ8j8tVxOnNrHuwr.3HIH8zEi2s3oRXPY?hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2FgCZkGrUNe9KDQBYnXVInZRNMQ_onwfkLvCsWsFWLIoqOGkGOd6_pmcEGuJ6Lm-t4.fzvS7nm7wh5uvXdd They seem on track with the new sales personnel. I'm looking for a pretty good bump in revenues this next quarter as the new sales team pick the low hanging fruit from the hospitals that we are already in for burns. Soft tissue wounds should be a no brainer for them.
👍️0
Fmello Fmello 1 년 전
Here are some screenshots of the slides from today's webinar:



















👍️ 1
Fmello Fmello 1 년 전
Avita donated Recell kits to Hawaiian burn centers to treat victims of that big wildfire.
👍️0
Fmello Fmello 1 년 전
The webinar just started.
👍️0
Fmello Fmello 1 년 전
AVITA Medical - Investor Webinar Briefing
Date & Time: Aug 15, 2023 06:00 PM central time

https://us02web.zoom.us/webinar/register/WN_QYXQA5P-TsGjPVD01tULxw#/registration
👍️0
Noseyrosey Noseyrosey 1 년 전
I agree
👍️0
MONYMAN3 MONYMAN3 1 년 전
I don't mind the higher expense since I view it as an investment in the future. Sales people can reach the 20+ kit sales in as little as 3-4 months. This ramp should really ramp once we get the automated system out in the field. That RCEL GO system greatly expands the target customers from mainly hospitals down to the clinic level.
👍️0
Fmello Fmello 1 년 전
I wonder if BARDA's Recell stockpile will be used to treat burn victims from the Hawaiian wildfires?
👍️0
Spetch Spetch 1 년 전
Pos could have better loss per share though
👍️0

최근 히스토리

NASDAQ
RCEL
Avita Medical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유